| The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. | |
| | |
MedLine Citation:
|
PMID: 11589691 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The reversible phosphorylation of proteins regulates almost all aspects of cell life, while abnormal phosphorylation is a cause or consequence of many diseases. Mutations in particular protein kinases and phosphatases gives rise to a number of disorders and many naturally occurring toxins and pathogens exert their effects by altering the phosphorylation states of intracellular proteins. In this lecture, I present an overview of the progress that is being made in developing specific inhibitors of protein kinases for the treatment of cancer and chronic inflammatory diseases and describe how recent advances in our understanding of the specificity and regulation of one particular protein kinase (GSK3) may facilitate the development of drugs to treat diabetes that would not have the potential to be oncogenic. I also discuss the exploitation of specific protein kinase inhibitors for the study of cell signalling and make recommendations for their effective use in cell-based assays. |
| | |
Authors:
|
P Cohen |
Publication Detail:
|
Type: Lectures; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: European journal of biochemistry / FEBS Volume: 268 ISSN: 0014-2956 ISO Abbreviation: Eur. J. Biochem. Publication Date: 2001 Oct |
Date Detail:
|
Created Date: 2001-10-08 Completed Date: 2001-12-04 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 0107600 Medline TA: Eur J Biochem Country: Germany |
Other Details:
|
Languages: eng Pagination: 5001-10 Citation Subset: IM |
Affiliation:
|
MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 4HN, Scotland, UK. p.cohen@dundee.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Calcium-Calmodulin-Dependent Protein Kinases
/
antagonists & inhibitors,
metabolism Diabetes Mellitus / drug therapy Enzyme Inhibitors / pharmacology, therapeutic use Glycogen Synthase Kinase 3 Humans Inflammation / drug therapy Neoplasms / drug therapy Phosphoprotein Phosphatases / antagonists & inhibitors Phosphorylation Protein Kinase Inhibitors Proteins / metabolism* Signal Transduction Stroke / drug therapy |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Inhibitors; 0/Protein Kinase Inhibitors; 0/Proteins; EC 2.7.11.17/Calcium-Calmodulin-Dependent Protein Kinases; EC 2.7.11.26/Glycogen Synthase Kinase 3; EC 3.1.3.16/Phosphoprotein Phosphatases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Octreotide LAR treatment throughout pregnancy in an acromegalic woman.
Next Document: The role of the TolC family in protein transport and multidrug efflux. From stereochemical certainty...